These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7793202)

  • 1. Recovery from neuromuscular blockade: residual curarisation following atracurium or vecuronium by bolus dosing or infusions.
    Fawcett WJ; Dash A; Francis GA; Liban JB; Cashman JN
    Acta Anaesthesiol Scand; 1995 Apr; 39(3):288-93. PubMed ID: 7793202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative residual block after intermediate-acting neuromuscular blocking drugs.
    Hayes AH; Mirakhur RK; Breslin DS; Reid JE; McCourt KC
    Anaesthesia; 2001 Apr; 56(4):312-8. PubMed ID: 11284816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recovery of neuromuscular function after infusion or intermittent bolus doses of atracurium or vecuronium.
    Gordon KL; Reilly CS
    Br J Anaesth; 1989 Mar; 62(3):269-73. PubMed ID: 2564782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous recovery of residual neuromuscular blockade after atracurium or vecuronium during isoflurane anaesthesia.
    Erkola O; Karhunen U; Sandelin-Hellqvist E
    Acta Anaesthesiol Scand; 1989 May; 33(4):290-4. PubMed ID: 2566251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative residual curarization from intermediate-acting neuromuscular blocking agents delays recovery room discharge.
    Butterly A; Bittner EA; George E; Sandberg WS; Eikermann M; Schmidt U
    Br J Anaesth; 2010 Sep; 105(3):304-9. PubMed ID: 20576632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the train-of-four fade profiles produced by vecuronium and atracurium.
    Fletcher JE; Sebel PS; Mick SA; Van Duys J; Ryan K
    Br J Anaesth; 1992 Feb; 68(2):207-8. PubMed ID: 1347231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extending a pipecuronium neuromuscular block. Increments of atracurium or vecuronium as an alternative to pipecuronium.
    Roberts SP; Ramsay TM; Healy TE; Wilson A; Pollard BJ
    Anaesthesia; 1993 Mar; 48(3):196-9. PubMed ID: 8096370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the onset time, duration of action, and fade characteristics of atracurium and vecuronium.
    Haines M
    AANA J; 1993 Dec; 61(6):592-6. PubMed ID: 7903505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit patients.
    Prielipp RC; Coursin DB; Scuderi PE; Bowton DL; Ford SR; Cardenas VJ; Vender J; Howard D; Casale EJ; Murray MJ
    Anesth Analg; 1995 Jul; 81(1):3-12. PubMed ID: 7598277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Train-of-four fade during onset of neuromuscular block with nondepolarising neuromuscular blocking agents.
    Gibson FM; Mirakhur RK
    Acta Anaesthesiol Scand; 1989 Apr; 33(3):204-6. PubMed ID: 2567104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerated onset of non-depolarizing neuromuscular blocking drugs: pancuronium, atracurium and vecuronium. A comparison with succinylcholine.
    Mehta MP; Sokoll MD; Gergis SD
    Eur J Anaesthesiol; 1988 Jan; 5(1):15-21. PubMed ID: 2897912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison between vecuronium and atracurium in myasthenia gravis.
    Chan KH; Yang MW; Huang MH; Hseu SS; Chang CC; Lee TY; Lin CY
    Acta Anaesthesiol Scand; 1993 Oct; 37(7):679-82. PubMed ID: 7902637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of vecuronium and atracurium during halothane anaesthesia in children.
    Sloan MH; Bissonnette B; Lerman J
    Anaesthesia; 1998 Jan; 53(1):36-40. PubMed ID: 9505740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of phenytoin on the magnitude and duration of neuromuscular block following atracurium or vecuronium.
    Ornstein E; Matteo RS; Schwartz AE; Silverberg PA; Young WL; Diaz J
    Anesthesiology; 1987 Aug; 67(2):191-6. PubMed ID: 2886081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Profile of the effect of succinylcholine after pre-curarization with atracurium, vecuronium or pancuronium].
    Ebeling BJ; Keienburg T; Hausmann D; Apffelstaedt C
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Jun; 31(5):304-8. PubMed ID: 8767244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical neuromuscular pharmacology of cisatracurium versus vecuronium during outpatient anesthesia.
    Stevens JB; Walker SC; Fontenot JP
    Anesth Analg; 1997 Dec; 85(6):1278-83. PubMed ID: 9390594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Potentiation of nondepolarizing muscle relaxants by nifedipine iv in inhalation anesthesia].
    Jelen-Esselborn S; Blobner M
    Anaesthesist; 1990 Mar; 39(3):173-8. PubMed ID: 1970460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of continuous infusion of vecuronium and atracurium in midline and paramedian laparotomies.
    Chaudhari LS; Shetty AN; Buddhi M; Krishnan G
    J Postgrad Med; 1999; 45(1):5-9. PubMed ID: 10734323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the neuromuscular blocking effects of atracurium, mivacurium, and vecuronium on the adductor pollicis and the orbicularis oculi muscle in humans.
    Rimaniol JM; Dhonneur G; Sperry L; Duvaldestin P
    Anesth Analg; 1996 Oct; 83(4):808-13. PubMed ID: 8831326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onset and duration of clinical relaxation of atracurium and vecuronium in patients on chronic nifedipine therapy.
    Bell PF; Mirakhur RK; Elliott P
    Eur J Anaesthesiol; 1989 Sep; 6(5):343-6. PubMed ID: 2571501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.